Connection

Aimee Mcrae-Clark to Female

Back to Details
This is a "connection" page, showing publications Aimee Mcrae-Clark has written about Female.
Aimee Mcrae-Clark
Connection Strength
1.095
Female
  1. Consideration of sex and gender differences in addiction medication response. Biol Sex Differ. 2022 06 27; 13(1):34.
    View in: PubMed
    Score: 0.044
  2. Sex and drug differences in stress, craving and cortisol response to the trier social stress task. Psychopharmacology (Berl). 2022 Sep; 239(9):2819-2827.
    View in: PubMed
    Score: 0.044
  3. The effect of oxytocin, gender, and ovarian hormones on stress reactivity in individuals with cocaine use disorder. Psychopharmacology (Berl). 2020 Jul; 237(7):2031-2042.
    View in: PubMed
    Score: 0.038
  4. Examining Stressors and Available Parenting Resources for Opioid-Using Mothers: Qualitative Findings from an Inpatient Substance Use Treatment Program. Community Ment Health J. 2020 04; 56(3):426-434.
    View in: PubMed
    Score: 0.036
  5. Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology. Pharmacol Biochem Behav. 2019 04; 179:22-26.
    View in: PubMed
    Score: 0.035
  6. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend. 2018 06 01; 187:270-277.
    View in: PubMed
    Score: 0.033
  7. Parenting outcomes of parenting interventions in integrated substance-use treatment programs: A systematic review. J Subst Abuse Treat. 2018 06; 89:52-59.
    View in: PubMed
    Score: 0.033
  8. Approach bias modification for cannabis use disorder: A proof-of-principle study. J Subst Abuse Treat. 2018 04; 87:16-22.
    View in: PubMed
    Score: 0.032
  9. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res. 2018; 16(2):143-150.
    View in: PubMed
    Score: 0.032
  10. Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women. Pharmacol Biochem Behav. 2018 02; 165:63-69.
    View in: PubMed
    Score: 0.032
  11. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
    View in: PubMed
    Score: 0.031
  12. Effect of oxytocin pretreatment on cannabis outcomes in a brief motivational intervention. Psychiatry Res. 2017 Mar; 249:318-320.
    View in: PubMed
    Score: 0.030
  13. Impact of gender on corticotropin-releasing factor and noradrenergic sensitivity in cocaine use disorder. J Neurosci Res. 2017 01 02; 95(1-2):320-327.
    View in: PubMed
    Score: 0.030
  14. Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women. Addict Behav. 2016 09; 60:197-202.
    View in: PubMed
    Score: 0.029
  15. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75.
    View in: PubMed
    Score: 0.028
  16. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37.
    View in: PubMed
    Score: 0.027
  17. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence. J Subst Abuse Treat. 2015 Oct; 57:70-4.
    View in: PubMed
    Score: 0.027
  18. Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):146-52.
    View in: PubMed
    Score: 0.026
  19. Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study. Psychopharmacology (Berl). 2013 Aug; 228(4):623-31.
    View in: PubMed
    Score: 0.023
  20. Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology (Berl). 2011 Nov; 218(1):49-58.
    View in: PubMed
    Score: 0.021
  21. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
    View in: PubMed
    Score: 0.019
  22. Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial. J Atten Disord. 2011 Oct; 15(7):539-44.
    View in: PubMed
    Score: 0.019
  23. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
    View in: PubMed
    Score: 0.018
  24. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
    View in: PubMed
    Score: 0.016
  25. Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addict Behav. 2007 Jul; 32(7):1433-40.
    View in: PubMed
    Score: 0.015
  26. Buspirone for treatment of marijuana dependence: a pilot study. Am J Addict. 2006 Sep-Oct; 15(5):404.
    View in: PubMed
    Score: 0.015
  27. Stress reactivity: biological and subjective responses to the cold pressor and Trier Social stressors. Hum Psychopharmacol. 2006 Aug; 21(6):377-85.
    View in: PubMed
    Score: 0.015
  28. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
    View in: PubMed
    Score: 0.012
  29. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
    View in: PubMed
    Score: 0.012
  30. Distress tolerance and reactivity to negative affective cues in naturalistic environments of cannabis-using emerging adults. Drug Alcohol Depend. 2022 09 01; 238:109588.
    View in: PubMed
    Score: 0.011
  31. A preliminary investigation of the role of intraindividual sleep variability in substance use treatment outcomes. Addict Behav. 2022 08; 131:107315.
    View in: PubMed
    Score: 0.011
  32. Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases ?-amyloid protein production in the brain. EBioMedicine. 2021 Dec; 74:103701.
    View in: PubMed
    Score: 0.011
  33. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychol Addict Behav. 2022 Aug; 36(5):505-514.
    View in: PubMed
    Score: 0.010
  34. Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend. 2021 01 01; 218:108383.
    View in: PubMed
    Score: 0.010
  35. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993.
    View in: PubMed
    Score: 0.009
  36. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
    View in: PubMed
    Score: 0.009
  37. Cortisol reactivity and situational drug use in cocaine-dependent females. Psychiatry Res. 2019 12; 282:112611.
    View in: PubMed
    Score: 0.009
  38. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population. J Stud Alcohol Drugs. 2019 09; 80(5):572-577.
    View in: PubMed
    Score: 0.009
  39. Cannabis Withdrawal in Adults With Attention-Deficit/Hyperactivity Disorder. Prim Care Companion CNS Disord. 2018 Feb 22; 20(1).
    View in: PubMed
    Score: 0.008
  40. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
    View in: PubMed
    Score: 0.008
  41. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
    View in: PubMed
    Score: 0.008
  42. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20.
    View in: PubMed
    Score: 0.008
  43. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
    View in: PubMed
    Score: 0.008
  44. Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls. Drug Alcohol Depend. 2016 May 01; 162:56-63.
    View in: PubMed
    Score: 0.007
  45. Determining menstrual phase in human biobehavioral research: A review with recommendations. Exp Clin Psychopharmacol. 2016 Feb; 24(1):1-11.
    View in: PubMed
    Score: 0.007
  46. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82.
    View in: PubMed
    Score: 0.007
  47. Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence. Psychiatry Res. 2015 Sep 30; 229(1-2):94-100.
    View in: PubMed
    Score: 0.007
  48. D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. Am J Addict. 2015 Apr; 24(3):217-224.
    View in: PubMed
    Score: 0.007
  49. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
    View in: PubMed
    Score: 0.006
  50. The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues. Addiction. 2014 Dec; 109(12):2062-70.
    View in: PubMed
    Score: 0.006
  51. Yohimbine administration and cue-reactivity in cocaine-dependent individuals. Psychopharmacology (Berl). 2014 Oct; 231(21):4157-65.
    View in: PubMed
    Score: 0.006
  52. Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):44-9.
    View in: PubMed
    Score: 0.006
  53. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):195-201.
    View in: PubMed
    Score: 0.006
  54. A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans. Psychopharmacology (Berl). 2013 Apr; 226(4):721-37.
    View in: PubMed
    Score: 0.006
  55. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study. Am J Drug Alcohol Abuse. 2013 Mar; 39(2):92-8.
    View in: PubMed
    Score: 0.006
  56. Association of elevated cytokines with childhood adversity in a sample of healthy adults. J Psychiatr Res. 2013 May; 47(5):604-10.
    View in: PubMed
    Score: 0.006
  57. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
    View in: PubMed
    Score: 0.006
  58. Associations between behavioral disinhibition and cocaine use history in individuals with cocaine dependence. Addict Behav. 2012 Oct; 37(10):1185-8.
    View in: PubMed
    Score: 0.005
  59. Brain activation to cocaine cues and motivation/treatment status. Addict Biol. 2014 Mar; 19(2):240-9.
    View in: PubMed
    Score: 0.005
  60. Does alexithymia explain variation in cue-elicited craving reported by methamphetamine-dependent individuals? Am J Addict. 2012 Mar-Apr; 21(2):130-5.
    View in: PubMed
    Score: 0.005
  61. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals. Psychopharmacology (Berl). 2013 Apr; 226(4):739-46.
    View in: PubMed
    Score: 0.005
  62. Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals. Addict Behav. 2012 Apr; 37(4):373-8.
    View in: PubMed
    Score: 0.005
  63. The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Am J Addict. 2011 Sep-Oct; 20(5):447-55.
    View in: PubMed
    Score: 0.005
  64. Psychoticism and neuroticism predict cocaine dependence and future cocaine use via different mechanisms. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):80-5.
    View in: PubMed
    Score: 0.005
  65. Influence of cocaine dependence and early life stress on pituitary-adrenal axis responses to CRH and the Trier social stressor. Psychoneuroendocrinology. 2010 Nov; 35(10):1492-500.
    View in: PubMed
    Score: 0.005
  66. Extinction of drug cue reactivity in methamphetamine-dependent individuals. Behav Res Ther. 2010 Sep; 48(9):860-5.
    View in: PubMed
    Score: 0.005
  67. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Am J Drug Alcohol Abuse. 2010 Mar; 36(2):106-13.
    View in: PubMed
    Score: 0.005
  68. Community-dwelling cocaine-dependent men and women respond differently to social stressors versus cocaine cues. Psychoneuroendocrinology. 2010 Jul; 35(6):798-806.
    View in: PubMed
    Score: 0.005
  69. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend. 2010 Jan 01; 106(1):21-7.
    View in: PubMed
    Score: 0.005
  70. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch Gen Psychiatry. 2009 Apr; 66(4):422-30.
    View in: PubMed
    Score: 0.004
  71. D-cycloserine and cocaine cue reactivity: preliminary findings. Am J Drug Alcohol Abuse. 2009; 35(6):434-8.
    View in: PubMed
    Score: 0.004
  72. Relationship between child abuse and adult smoking. Int J Psychiatry Med. 2009; 39(4):417-26.
    View in: PubMed
    Score: 0.004
  73. Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology. 2008 Jun; 33(5):560-8.
    View in: PubMed
    Score: 0.004
  74. Early life trauma and sensitivity to current life stressors in individuals with and without cocaine dependence. Am J Drug Alcohol Abuse. 2008; 34(4):389-96.
    View in: PubMed
    Score: 0.004
  75. Differences in early onset alcohol use and heavy drinking among persons with childhood and adulthood trauma. Am J Addict. 2007 Nov-Dec; 16(6):439-42.
    View in: PubMed
    Score: 0.004
  76. Assessment of club drug use in a treatment-seeking sample of individuals with marijuana dependence. Am J Addict. 2007 Nov-Dec; 16(6):484-7.
    View in: PubMed
    Score: 0.004
  77. Daily stressor sensitivity, abuse effects, and cocaine use in cocaine dependence. Addict Behav. 2007 Dec; 32(12):3015-25.
    View in: PubMed
    Score: 0.004
  78. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol. 2006 Sep; 67(5):700-6.
    View in: PubMed
    Score: 0.004
  79. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res. 2006 Jun; 30(6):938-46.
    View in: PubMed
    Score: 0.004
  80. PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma. Psychoneuroendocrinology. 2006 May; 31(4):501-9.
    View in: PubMed
    Score: 0.004
  81. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.